Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0PFQKN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
EDC-2
|
|||||
| Synonyms |
EDC2; EDC 2; extracellular drug conjugate-2; extracellular drug conjugate-2 (Centrose)
Click to Show/Hide
|
|||||
| Organization |
Centrose LLC
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Head and neck cancer [ICD11:2B60-2B6E]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
1
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Basigin (BSG)
|
Antigen Info | ||||
| Payload Name |
Glycosylation scillarenin
|
Payload Info | ||||
| Linker Name |
CEN010-105
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.